Treatment of murine tumors with lethal doses of dimethylmyleran and autologous bone marrow
- 1 August 1981
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 17 (8) , 905-912
- https://doi.org/10.1016/0014-2964(81)90313-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- HUMAN MARROW TRANSPLANTATIONTransplantation, 1979
- Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical TwinNew England Journal of Medicine, 1979
- Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapseCancer, 1978
- Marrow Transplantation in the Treatment of Acute LeukemiaPublished by Elsevier ,1978
- HEMOPOIETIC GRAFTS BETWEEN DLA-IDENTICAL CANINE LITTERMATES FOLLOWING DIMETHYL MYLERANTransplantation, 1977
- Use of Dimethylmyleran in Adoptive Chemoimmunotherapy of Two Murine Leukemias 2JNCI Journal of the National Cancer Institute, 1976
- Effect of Dimethylmyleran on Cell-Mediated Immunity to a Tumor Allograft2JNCI Journal of the National Cancer Institute, 1975
- Contribution of host immunity to cyclophosphamide therapy of a chemically‐induced murine sarcomaInternational Journal of Cancer, 1973
- Treatment of a mouse lymphoma by L‐asparaginase: Success depends on the host's immune responseInternational Journal of Cancer, 1973
- TREATMENT OF MOLONEY LYMPHOMA WITH LETHAL DOSES OF DIMETHYL-MYLERAN COMBINED WITH INJECTIONS OF HÆMOPOIETIC CELLSThe Lancet, 1969